Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Pines

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
Oncotarget|May 28, 2015
Inhibition of muscle fibrosis results in increases in both utrophin levels and the number of revertant myofibers in Duchenne muscular dystrophyOshrat Levi, Olga Genin, Corrado Angelini, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|May 13, 2011
Hsp90 and angiogenesis in bone disorders--lessons from the avian growth plateAyelet Herzog, Olga Genin, Ahron Hasdai, et al.
Cancer Biology & Therapy|January 19, 2006
Halofuginone inhibits tumor growth in the polyoma middle T antigen mouse via a thrombospondin-1 independent mechanismKaren O Yee, Caitlin M Connolly, Mark Pines, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|September 14, 2002
Mechanical strain regulation of the chicken glypican-4 gene expression in the avian eggshell glandIrena Lavelin, Noam Meiri, Miriam Einat, et al.
Biochimica Et Biophysica Acta|October 11, 2015
Halofuginone promotes satellite cell activation and survival in muscular dystrophiesHila Barzilai-Tutsch, Anna Bodanovsky, Hadar Maimon, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 14, 2004
A protective effect of pyrrolidine dithiocarbamate in a rat model of liver cirrhosisRafael Bruck, Ron Schey, Hussein Aeed, et al.
Pancreas|May 6, 2010
Inhibition of pancreatic stellate cell activation by halofuginone prevents pancreatic xenograft tumor developmentItai Spector, Hen Honig, Norifumi Kawada, et al.
Histology and Histopathology|January 11, 2019
Hydroxy group requirement for halofuginone-dependent inhibition of muscle fibrosis and improvement of histopathology in the mdx mouse model for Duchenne muscular dystrophyGili Wellner, Sharon Mordechay, Paul Evans, et al.
Plos One|August 1, 2012
Involvement of host stroma cells and tissue fibrosis in pancreatic tumor development in transgenic miceItai Spector, Yael Zilberstein, Adi Lavy, et al.
International Journal of Molecular Sciences|July 2, 2021
Differential Effects of Halofuginone Enantiomers on Muscle Fibrosis and Histopathology in Duchenne Muscular DystrophySharon Mordechay, Shaun Smullen, Paul Evans, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Oncotarget|May 28, 2015
Inhibition of muscle fibrosis results in increases in both utrophin levels and the number of revertant myofibers in Duchenne muscular dystrophyOshrat Levi, Olga Genin, Corrado Angelini, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|May 13, 2011
Hsp90 and angiogenesis in bone disorders--lessons from the avian growth plateAyelet Herzog, Olga Genin, Ahron Hasdai, et al.
Cancer Biology & Therapy|January 19, 2006
Halofuginone inhibits tumor growth in the polyoma middle T antigen mouse via a thrombospondin-1 independent mechanismKaren O Yee, Caitlin M Connolly, Mark Pines, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|September 14, 2002
Mechanical strain regulation of the chicken glypican-4 gene expression in the avian eggshell glandIrena Lavelin, Noam Meiri, Miriam Einat, et al.
Biochimica Et Biophysica Acta|October 11, 2015
Halofuginone promotes satellite cell activation and survival in muscular dystrophiesHila Barzilai-Tutsch, Anna Bodanovsky, Hadar Maimon, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 14, 2004
A protective effect of pyrrolidine dithiocarbamate in a rat model of liver cirrhosisRafael Bruck, Ron Schey, Hussein Aeed, et al.
Pancreas|May 6, 2010
Inhibition of pancreatic stellate cell activation by halofuginone prevents pancreatic xenograft tumor developmentItai Spector, Hen Honig, Norifumi Kawada, et al.
Histology and Histopathology|January 11, 2019
Hydroxy group requirement for halofuginone-dependent inhibition of muscle fibrosis and improvement of histopathology in the mdx mouse model for Duchenne muscular dystrophyGili Wellner, Sharon Mordechay, Paul Evans, et al.
Plos One|August 1, 2012
Involvement of host stroma cells and tissue fibrosis in pancreatic tumor development in transgenic miceItai Spector, Yael Zilberstein, Adi Lavy, et al.
International Journal of Molecular Sciences|July 2, 2021
Differential Effects of Halofuginone Enantiomers on Muscle Fibrosis and Histopathology in Duchenne Muscular DystrophySharon Mordechay, Shaun Smullen, Paul Evans, et al.
Pageof 6